Analysis demonstrates reduced patient burden in drug development through decentralized clinical trials, suggesting new digital platforms may enhance accessibility.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sonali Mallick (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: